This site is intended only for healthcare professionals resident in the United Kingdom

Information relating to specific disease areas aligned to Pfizer’s portfolio and other resources designed for Pfizer medicines.

See all Therapy areas

Learn about ATTR-CM and uncover the differences between hereditary and Wild-type ATTR-CM

Learn about the red flags that may raise suspicion of and techniques used to diagnose ATTR-CM

Explore a range of educational resources to support the diagnosis of ATTR-CM

Click here for Vyndaqel®▼ (tafamidis) Prescribing Information. Adverse event reporting information can be found at the bottom of the page.

On Demand Congresses

BCS 2021- British Cardiovascular Society: 

Dr Nigel Lewis (Northern General Hospital, Sheffield​​​​​​​
Dr Kate Gatenby (Leeds General Infirmary, Leeds
Dr William Moody (Queen Elizabeth Hospital, Birmingham & the Midlands Amyloid Service)

Detect, differentiate and diagnose: Identifying and managing ATTR-CM
Catch up with our panel of expert speakers from the BCS 2021 as they describe the clinical journey of a patient with ATTR-CM from detection through to diagnosis and management.

Prescribing information:
Aldactone (spironolactone) 25mg tablets
Aldactone (spironolactone) 50mg tablets
Aldactone (spironolactone) 100mg tablets

BSH 2021- British Society for Heart Failure:

​​​​​​​Dr Lisa Anderson (St George's Hospital, London)
Dr Robert Cooper (Liverpool Heart and Chest Hospital, Liverpool)

Future directions for management of cardiac amyloidosis

Dr Lisa Anderson provides an overview of the diagnosis and early management of cardiac amyloidosis and Dr Robert Cooper discusses the emerging treatment strategies.

Crack The Code- Unmasking and Addressing ATTR-CM in Your Practice Webinar 2020:

​​​​​​​Dr Pablo Garcia-Pavia (Hospital Puerta de Hierro, Madrid)

A Disease Enigma: Unlocking the Clinical Clues of ATTR-CM

Dr Pablo Garcia-Pavia provides an overview of ATTR-CM and the initial patient presentation. He presents at the live Crack the Code: Unmasking and Addressing ATTR-CM in Your Practice webinar in 2020.

Crack The Code- Unmasking and Addressing ATTR-CM in Your Practice Webinar 2020:
​​​​​​​Professor Claudio Rapezzi (Cardiovascular Centre, University of Ferrara, Ferrara)​​​​​​​

Challenging Case of Heart Failure: Putting the Clues of ATTR-CM Together

Claudio Rapezzi discusses what should prompt suspicion of ATTR-CM in this patient and how suspicion can be confirmed through diagnostic techniques. 

Crack The Code- Unmasking and Addressing ATTR-CM in Your Practice Webinar 2020:

Thibaud Damy, MD, PhD (University Hospital Henri Mondor, Creteil)

​​​​​​​Cracked the Code: What to Do Next? A Treatment Option for Patients with ATTR-CM

Dr Thibaud Damy reviews the clinical data for a treatment option for ATTR-CM. 

Explore more

See other educational resources available

Explore more

PP-VYN-GBR-0894. October 2021

Quick Links

Register to receive tailored marketing information from Pfizer by email

Stay up to date with the latest relevant healthcare, medical and promotional information about medicines and vaccines promoted by Pfizer.

PP-PFE-GBR-2809. October 2020

Sign up now

For UK Healthcare Professionals*

These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.

I confirm that I am a healthcare professional* resident in the United Kingdom.

If you select 'No', you will be redirected to where you will be able to access reference information on Pfizer's prescription medicines.

*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.

PP-PFE-GBR-2688. December 2020